Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.
2.

The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.

Duh MS, Cahill KE, Paradis PE, Cremieux PY, Greenberg PE.

Expert Opin Pharmacother. 2009 Oct;10(14):2317-28. doi: 10.1517/14656560903140525. Review.

PMID:
19663636
3.

Understanding therapeutic equivalence in epilepsy.

Sankar R, Glauser TA.

CNS Spectr. 2010 Feb;15(2):112-23. Review.

PMID:
20414156
4.

[Generic drugs in the treatment of epilepsy].

González de Dios J, Ochoa-Sangrador C, Sempere AP.

Rev Neurol. 2005 Dec 1-15;41(11):676-83. Review. Spanish.

5.

Prescribing antiepileptic drugs: should patients be switched on the basis of cost?

Jobst BC, Holmes GL.

CNS Drugs. 2004;18(10):617-28. Review.

PMID:
15270592
6.

Requirements for generic antiepileptic medicines: a clinical perspective.

Trinka E, Krämer G, Graf M.

J Neurol. 2011 Dec;258(12):2128-32. doi: 10.1007/s00415-011-6126-6. Epub 2011 Jun 11. Review.

PMID:
21667222
7.

Antiepileptic drugs: generic versus branded treatments.

Heaney DC, Sander JW.

Lancet Neurol. 2007 May;6(5):465-8. Review.

PMID:
17434101
8.

Current approaches to the use of generic antiepileptic drugs.

Krämer G, Biraben A, Carreno M, Guekht A, de Haan GJ, Jedrzejczak J, Josephs D, van Rijckevorsel K, Zaccara G.

Epilepsy Behav. 2007 Aug;11(1):46-52. Epub 2007 May 29. Review.

PMID:
17537678
9.

Generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studies.

Yamada M, Welty TE.

Ann Pharmacother. 2011 Nov;45(11):1406-15. doi: 10.1345/aph.1Q349. Epub 2011 Oct 25. Review.

PMID:
22028417
10.

The importance of drug interactions in epilepsy therapy.

Patsalos PN, Fröscher W, Pisani F, van Rijn CM.

Epilepsia. 2002 Apr;43(4):365-85. Review.

11.

Prescribing generic antiepileptic drugs: Issues and concerns for nurse practitioners.

Barrett MW.

J Am Acad Nurse Pract. 2010 Jun;22(6):300-4. doi: 10.1111/j.1745-7599.2010.00511.x. Review.

PMID:
20536627
12.

Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.

Kesselheim AS, Stedman MR, Bubrick EJ, Gagne JJ, Misono AS, Lee JL, Brookhart MA, Avorn J, Shrank WH.

Drugs. 2010 Mar 26;70(5):605-21. doi: 10.2165/10898530-000000000-00000. Review.

13.

Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability.

Bialer M, Midha KK.

Epilepsia. 2010 Jun;51(6):941-50. doi: 10.1111/j.1528-1167.2010.02573.x. Epub 2010 Apr 8. Review.

14.

The use of generic medication in epilepsy: a review of potential issues and challenges.

Van Paesschen W, Hauman H, Lagae L.

Eur J Paediatr Neurol. 2009 Mar;13(2):87-92. doi: 10.1016/j.ejpn.2008.07.007. Epub 2008 Sep 13. Review.

PMID:
18790656
15.

Efficacy and adverse effects of established and new antiepileptic drugs.

Mattson RH.

Epilepsia. 1995;36 Suppl 2:S13-26. Review.

PMID:
8784211
16.

Are there potential problems with generic substitution of antiepileptic drugs? A review of issues.

Crawford P, Feely M, Guberman A, Kramer G.

Seizure. 2006 Apr;15(3):165-76. Epub 2006 Feb 28. Review.

17.

Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.

Hirsch LJ, Weintraub D, Du Y, Buchsbaum R, Spencer HT, Hager M, Straka T, Bazil CW, Adams DJ, Resor SR Jr, Morrell MJ.

Neurology. 2004 Sep 28;63(6):1022-6. Review.

PMID:
15452293
18.
19.

Once-daily lamotrigine extended release for epilepsy management.

Rheims S, Ryvlin P.

Expert Rev Neurother. 2009 Feb;9(2):167-73. doi: 10.1586/14737175.9.2.167. Review.

PMID:
19210192
20.

Lamotrigine versus other antiepileptic drugs: a star rating system is born.

Brodie MJ.

Epilepsia. 1994;35 Suppl 5:S41-6. Review.

PMID:
8039470

Supplemental Content

Support Center